Exelon is a medication classified as a reversible acetylcholinesterase inhibitor used in the treatment of cognitive decline associated with neurodegenerative disorders. Its pharmacological action involves binding to the active site of brain cholinesterases, thereby preventing the breakdown of the neurotransmitter acetylcholine. By preserving acetylcholine concentrations, the drug enhances cholinergic signaling within cortical and subcortical pathways. The increased cholinergic activity contributes to measurable improvements in memory, attention, and functional abilities in affected patients. The reversible nature of inhibition allows continuous modulation of enzyme activity without complete and permanent loss of function. Exelon also exhibits modest inhibition of butyrylcholinesterase, further supporting its central nervous system effects. The medication is administered orally and undergoes hepatic metabolism that does not significantly alter its active concentration over time. Through this mechanism the therapeutic purpose of Exelon is to slow the progression of cognitive symptoms associated with the underlying disease.

Exelon is a cholinesterase inhibitor used to treat mild to moderate dementia associated with alzheimer disease. It works by increasing the levels of acetylcholine in the brain which enhances communication between neurons. The active ingredient rivastigmine blocks the activity of both acetylcholinesterase and butyrylcholinesterase enzymes. This blockade prevents the breakdown of acetylcholine thereby restoring cholinergic neurotransmission. The resulting increase in cholinergic signaling improves cognitive function and daily living activities. Pharmacodynamically Exelon produces dose-dependent inhibition of peripheral and central cholinesterases leading to sustained elevation of synaptic acetylcholine. Its pharmacokinetic profile shows high bioavailability after oral administration and a half-life of approximately two hours.

Exelon may cause nausea, vomiting, and diarrhea. Loss of appetite and weight loss are also reported side effects. Headache, dizziness, and fatigue often occur during treatment. Muscle cramps or weakness can affect some patients. Skin reactions such as rash or itching may develop. Changes in blood pressure or heart rate have been observed. These side effects are generally mild to moderate and may lessen with continued use.

Exelon may cause nausea, vomiting, and loss of appetite in some patients. Diarrhea and stomach discomfort are also reported side effects. Some individuals experience dizziness, headache, or sleep disturbances. Muscle weakness or tremor can occur, especially in older adults. Fatigue and decreased coordination are additional reactions observed. Serious reactions are rare but may include irregular heartbeat or severe allergic responses.